Dergiler / GORM:Gynecology Obstetrics & Reproductive Medicine / 2022 / Cilt: 28 - Sayı: 1

Effect of “Time to Surgery” on the Endometrial Cancer Prognosis

Sayfa
89–97
Yayın Tarihi
2022-10-17
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

CONCLUSION: Time delay between diagnosis to surgery of the patients with endometrial cancer has no prognostic importance for recurrence and survival outcomes.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:OBJECTIVE: Endometrial cancer is the most common gynecological cancer in developed countries.
📊
Temel Bulgular & Veri:We divided the patients into two groups regarding before and after 8 weeks from diagnosis to surgery.
💡
Sonuç & Katkı:CONCLUSION: Time delay between diagnosis to surgery of the patients with endometrial cancer has no prognostic importance for recurrence and survival outcomes.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

OBJECTIVE: Endometrial cancer is the most common gynecological cancer in developed countries. Our study aims to determine the effect of the time between diagnosis and surgery of endometrial cancer on the prognosis of the disease. STUDY DESIGN: Patients who were diagnosed with epithelial type endometrial cancer and did not receive preoperative chemotherapy, radiotherapy, or hormonal therapy were included in the study. RESULTS: Two hundred eighty-five patients were included in the study. We divided the patients into two groups regarding before and after 8 weeks from diagnosis to surgery. Clinical characteristics of the patients were comparable between the groups, except for comorbid conditions and body mass index. Using cox-regression analysis, time to operation did not have a significant effect on both recurrence and cancer-associated death risk. The log-rank test analysis also showed that there was no significant difference in progression-free survival and disease-specific survival between the patients. There was no significant difference between the groups in terms of progression-free survival and disease-specific survival for cases with endometrioid type grade 1-2 tumors. There was also no significant difference between the groups regarding progression-free survival and disease-specific survival in the patients with tumors of endometrioid type grade 3 and non-endometrioid histology. CONCLUSION: Time delay between diagnosis to surgery of the patients with endometrial cancer has no prognostic importance for recurrence and survival outcomes.

🔖

Bu Makaleye Atıf Yap

ONDER, S., TOPUZ, S., CELIK, H. G., CELIK, E., SALIHOGLU, M. Y., SOZEN, H., CELIKSOY, H. Y. (2022). Effect of “Time to Surgery” on the Endometrial Cancer Prognosis. GORM:Gynecology Obstetrics & Reproductive Medicine, Cilt: 28 - Sayı: 1, 89–97. https://ajindex.com/articles/525802

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (11)

  1. Concin N, Creutzberg CL, Vergote I, Cibula D, Mirza MR, Marnitz S, et al. ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma. Virchows Arch. 2021;478(2):153-90. Doi: 10.1007/s004 28-020-03007-z
  2. Chan JK, Sherman AE, Kapp DS, Zhang R, Osann KE, Maxwell L, et al. Influence of gynecologic oncologists on the survival of patients with endometrial cancer. J Clin Oncol. 2011;29(7):832-8. Doi: 10.1200/JCO.2010.31. 2124
  3. Ramirez PT, Chiva L, Eriksson AGZ, Frumovitz M, Fagotti A, Gonzalez Martin A, et al. COVID-19 Global Pandemic: Options for Management of Gynecologic Cancers. Int J Gynecol Cancer. 2020;30(5):561-3. Doi: 10.1136/ijgc-2020-001419
  4. Menczer J. Diagnosis and treatment delay in gynecological malignancies. Does it affect outcome? Int J Gynecol Cancer. 2000;10(2):89-94. Doi: 10.1046/j.1525-1438. 2000.00020.x
  5. Pergialiotis V, Haidopoulos D, Tzortzis AS, Antonopoulos I, Thomakos N, Rodolakis A. The impact of waiting intervals on survival outcomes of patients with endometrial cancer: A systematic review of the literature. Eur J Obstet Gynecol Reprod Biol. 2020;246:1-6. Doi: 10.1016/j.ejogrb.2020.01.004
  6. Colombo I, Zaccarelli E, Del Grande M, Tomao F, Multinu F, Betella I, et al. ESMO management and treatment adapted recommendations in the COVID-19 era: gynaecological malignancies. ESMO Open. 2020;5(Suppl 3): e000827. Doi: 10.1136/esmoopen-2020-000827
  7. Menczer J, Krissi H, Chetrit A, Gaynor J, Lerner L, BenBaruch G, et al. The effect of diagnosis and treatment delay on prognostic factors and survival in endometrial carcinoma. Am J Obstet Gynecol. 1995;173(3 Pt 1):774- 8. Doi: 10.1016/0002-9378(95)90340-2
  8. Pirog EC, Heller DS, Westhoff C. Endometrial adenocarcinoma-lack of correlation between treatment delay and tumor stage. Gynecol Oncol. 1997;67(3):303-8. Doi: 10.1006/gyno.1997.4874
  9. Crawford SC, Davis JA, Siddiqui NA, de Caestecker L, Gillis CR, Hole D, et al. The waiting time paradox: population based retrospective study of treatment delay and survival of women with endometrial cancer in Scotland. BMJ. 2002;325(7357):196. Doi: 10.1136/bmj.325.7357. 196
  10. Elit LM, O’Leary EM, Pond GR, Seow HY. Impact of wait times on survival for women with uterine cancer. J Clin Oncol. 2014;32(1):27-33. Doi: 10.1200/JCO.2013. 51.3671
  11. Matsuo K, Opper NR, Ciccone MA, Garcia J, Tierney KE, Baba T, et al. Time interval between endometrial biopsy and surgical staging for type I endometrial cancer: associa